These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 29730444)

  • 1. ARID1A loss in cancer: Towards a mechanistic understanding.
    Mathur R
    Pharmacol Ther; 2018 Oct; 190():15-23. PubMed ID: 29730444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice.
    Mathur R; Alver BH; San Roman AK; Wilson BG; Wang X; Agoston AT; Park PJ; Shivdasani RA; Roberts CW
    Nat Genet; 2017 Feb; 49(2):296-302. PubMed ID: 27941798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Chromatin Remodeling Component Arid1a Is a Suppressor of Spontaneous Mammary Tumors in Mice.
    Kartha N; Shen L; Maskin C; Wallace M; Schimenti JC
    Genetics; 2016 Aug; 203(4):1601-11. PubMed ID: 27280691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.
    Kelso TWR; Porter DK; Amaral ML; Shokhirev MN; Benner C; Hargreaves DC
    Elife; 2017 Oct; 6():. PubMed ID: 28967863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential therapeutic targets in ARID1A-mutated cancers.
    Bitler BG; Fatkhutdinov N; Zhang R
    Expert Opin Ther Targets; 2015; 19(11):1419-22. PubMed ID: 26125128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.
    Guan B; Wang TL; Shih IeM
    Cancer Res; 2011 Nov; 71(21):6718-27. PubMed ID: 21900401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting ARID1A mutations in cancer.
    Mullen J; Kato S; Sicklick JK; Kurzrock R
    Cancer Treat Rev; 2021 Nov; 100():102287. PubMed ID: 34619527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma.
    Zhang S; Zhou YF; Cao J; Burley SK; Wang HY; Zheng XFS
    Cancer Res; 2021 Nov; 81(22):5652-5665. PubMed ID: 34429326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor suppressor role of chromatin-remodeling factor ARID1A].
    Guo XQ; Zhang QX; Huang WR; Duan XL; Cai ZM
    Yi Chuan; 2013 Mar; 35(3):255-61. PubMed ID: 23575531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SWI/SNF BAF-A complex is essential for neural crest development.
    Chandler RL; Magnuson T
    Dev Biol; 2016 Mar; 411(1):15-24. PubMed ID: 26806701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF.
    Chandler RL; Brennan J; Schisler JC; Serber D; Patterson C; Magnuson T
    Mol Cell Biol; 2013 Jan; 33(2):265-80. PubMed ID: 23129809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance.
    Zhang X; Zhang Y; Yang Y; Niu M; Sun S; Ji H; Ma Y; Yao G; Jiang Y; Shan M; Zhang G; Pang D
    Cancer Epidemiol; 2012 Jun; 36(3):288-93. PubMed ID: 21889920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of
    Xu S; Tang C
    Front Oncol; 2021; 11():745187. PubMed ID: 34671561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging roles of ARID1A in tumor suppression.
    Wu RC; Wang TL; Shih IeM
    Cancer Biol Ther; 2014 Jun; 15(6):655-64. PubMed ID: 24618703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma.
    Lichner Z; Scorilas A; White NM; Girgis AH; Rotstein L; Wiegand KC; Latif A; Chow C; Huntsman D; Yousef GM
    Am J Pathol; 2013 Apr; 182(4):1163-70. PubMed ID: 23416164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies.
    Caumanns JJ; Wisman GBA; Berns K; van der Zee AGJ; de Jong S
    Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):176-184. PubMed ID: 30025943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response.
    Bakr A; Corte GD; Veselinov O; Kelekçi S; Chen MM; Lin YY; Sigismondo G; Iacovone M; Cross A; Syed R; Jeong Y; Sollier E; Liu CS; Lutsik P; Krijgsveld J; Weichenhan D; Plass C; Popanda O; Schmezer P
    Nucleic Acids Res; 2024 Jun; 52(10):5698-5719. PubMed ID: 38587186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of mutated SWI/SNF complexes in the initiation and development of hepatocellular carcinoma and its regulatory effect on the immune system: A review.
    Hu B; Lin JZ; Yang XB; Sang XT
    Cell Prolif; 2020 Apr; 53(4):e12791. PubMed ID: 32162380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chromatin remodeling defects and cancer: the SWI/SNF example].
    Bourdeaut F; Bièche I
    Bull Cancer; 2012 Dec; 99(12):1133-40. PubMed ID: 23222069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAFfling pathologies: Alterations of BAF complexes in cancer.
    Arnaud O; Le Loarer F; Tirode F
    Cancer Lett; 2018 Apr; 419():266-279. PubMed ID: 29374542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.